1. Main page
  2. Biotechnology
  3. Vivakor

Vivakor

2 Decision Makers · 2 Verified Contacts & Email Format

vivakor.com
📍 South Salt Lake, Utah, United StatesBiotechnology🗓 Est. 2006👥 11–50 employees

About Vivakor

Vivakor is a biomedical company that focuses on the R&D of a range of medical devices and pharmaceuticals to improve human health.

Email Format

{first_name}@vivakor.com — 100.0%

sarah@vivakor.com

Leadership & Decision Makers

Contact details of 2 Vivakor decision makers

Daniel Hashim

Chief Scientific Officer

  • Work email

    d****l@vivakor.com

Tyler Nelson

Chief Financial Officer

General Emails

General company emails, e.g. customer support lines

    info@vivakor.com

    General Inquiries

    949-281-2606info@vivakor.com

    General Inquiries

    Contact949-281-2606info@vivakor.com

    General Inquiries

    matt@vivakor.com

    Unclassified inbox

    yzhou@vivakor.com

    Unclassified inbox

Verify Vivakor Emails

Similar Companies like Vivakor

Cullinan Oncology

cullinanoncology.com
Pharmaceuticals · Cambridge, MA · Est. 2017 · 11–50 employees

HQ: Cambridge, MA

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Cytokinetics

cytokinetics.com
Pharmaceuticals · South San Francisco, California, United States · Est. 1998 · 251–500 employees · $50M–$100M

HQ: South San Francisco, California, United States

BridgeBio

bridgebio.com
Biotechnology · Palo Alto, CA · Est. 2015 · 251–500 employees

HQ: Palo Alto, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 30/07/2025

vivakor.com

(949) 281-2606

South Salt Lake, Utah, United States

Legal Name: Vivakor Inc.
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Founded Date: 2006
Company Type: For Profit
Stock Symbol: NASDAQ:VIVK
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: (949) 281-2606
Last Investment Activity: Mar 6, 2024
Investments Activity: Mar 6, 2024 Mar 4, 2024 Oct 8, 2022

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.